D5 receptor
Dopamine receptor D5, also known as D5 receptor, is a protein that in humans is encoded by the DRD5 gene. It is one of the five main types of dopamine receptor. Dopamine receptors are a class of G protein-coupled receptors that are prominent in the vertebrate central nervous system (CNS). The D5 receptor is particularly important in the brain and plays a vital role in the neurological processes that modulate cognition, reward, and voluntary movement.
Structure[edit | edit source]
The D5 receptor is structurally similar to the D1 receptor, and both are members of the D1-like family of dopamine receptors, which also includes D1. Like other dopamine receptors, the D5 receptor is a seven-transmembrane domain G protein-coupled receptor that interacts with G proteins to initiate a complex set of intracellular signaling pathways.
Function[edit | edit source]
The D5 receptor is primarily coupled to the Gα_s subunit of G proteins, which activates adenylyl cyclase and increases levels of cAMP within the cell. This activation influences many downstream signaling pathways that result in neuronal excitability, synaptic plasticity, and the modulation of dopamine release.
D5 receptors are expressed in various regions of the brain, including the prefrontal cortex, hippocampus, and substantia nigra, areas involved in memory, attention, and motor control. The receptor's role in these regions suggests its involvement in functions such as learning, memory enhancement, and the modulation of dopamine-related disorders such as schizophrenia and Parkinson's disease.
Clinical Significance[edit | edit source]
Alterations in D5 receptor function and expression have been implicated in several neuropsychiatric disorders. For example, genetic variations in the DRD5 gene have been associated with susceptibility to attention deficit hyperactivity disorder (ADHD), suggesting that D5 receptor dysfunction may be involved in the pathophysiology of ADHD.
Furthermore, because of its role in modulating dopamine signaling in the brain, the D5 receptor is also a potential target for the treatment of disorders such as schizophrenia and Parkinson's disease. Drugs that can specifically target the D5 receptor may offer new therapeutic options for these conditions.
Research[edit | edit source]
Research on the D5 receptor includes studies aimed at understanding its exact role in the CNS, its involvement in disease states, and its potential as a target for pharmacological intervention. Ongoing research is crucial for developing more effective treatments for neurological and psychiatric conditions involving dopaminergic dysfunction.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD